Tradestie Institutional Equity Comparison Engine

BMRA vs DCTH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DCTH Overall Edge

DCTH Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BMRA trades at N/M Forward P/E with -125.2% operating margin (-8.3% YoY revenue) versus DCTH at N/M Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DCTH
BMRA N/M vs DCTH N/M Fwd P/E
Growth & Margin Winner DCTH
Op Margin -125.2% vs 5.2% ยท YoY -8.3% vs +70.7%
Momentum & Technical Winner DCTH
1Y -45.6% vs +128.6% ยท 52W Pos 5% vs 80%
Options & Structure Winner DCTH
UNCLASSIFIED (N/A IV) vs BREAKOUT (43rd %ile IV)
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.36
+0.0% 1D
Market Cap $6.0M
1M Return -26.49%
1Y Return -45.6%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap $743.8M
1M Return +39.77%
1Y Return +128.57%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BMRA -45.6% DCTH +128.57% Spread: +174.17 pp (DCTH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BMRA Revenue DCTH Revenue BMRA Op. Margin DCTH Op. Margin Margin Edge
FY2019 $10M N/A -46.4% N/A BMRA
FY2020 $10M N/A -41.0% N/A BMRA
FY2021 $10M $0M -104.2% -690.0% BMRA
FY2022 $20M $0M -24.0% -1245.1% BMRA
FY2023 $10M $0M -135.3% -1849.0% BMRA
FY2024 $10M $40M -117.6% -33.4% DCTH
FY2025 $10M $90M -96.7% 0.8% DCTH
FY2026 $0M N/A -119.5% N/A BMRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BMRA (2) vs DCTH (7)
Institutional Metric BMRA DCTH Criterion Row Winner
Market Capitalization Scale $6.0M $743.8M Larger Scale DCTH
Trailing P/E Ratio Valuation N/M 133.6x Lower Multiple DCTH
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -8.3% +70.7% Higher Growth DCTH
Operating Margin (TTM) Profitability -125.2% 5.2% Higher Margin DCTH
Net Profit Margin Profitability -115.5% 6.0% Higher Margin DCTH
Return on Equity (ROE) Capital Efficiency -113.8% 5.4% Higher ROE DCTH
52-Week Range Position Momentum 5% ($1โ€“$3) 80% ($8โ€“$23) Stronger Trend DCTH
Beta / 30D Volatility Risk Regime 0.67ฮฒ ยท 62% Vol 1.63ฮฒ ยท 131% Vol Lower Realized Risk BMRA
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 35.9 / 100 (SELL) Higher Composite BMRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BMRA vs DCTH Buy Guide
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BMRA nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.